Novel Oral AntiCoagulants Market - Global Outlook and Forecast 2021-2027

Code: RW00014556124
Market Monitor Global
Oct-2021
Life Sciences
109 Pages

This report contains market size and forecasts of Novel Oral AntiCoagulants (NOAC) in global, including the following market information:
Global Novel Oral AntiCoagulants (NOAC) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Novel Oral AntiCoagulants (NOAC) Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Novel Oral AntiCoagulants (NOAC) companies in 2020 (%)
The global Novel Oral AntiCoagulants (NOAC) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Oral AntiCoagulants (NOAC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Oral AntiCoagulants (NOAC) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) Market Segment Percentages, By Type, 2020 (%)
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors

Global Novel Oral AntiCoagulants (NOAC) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) Market Segment Percentages, By Application, 2020 (%)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others

Global Novel Oral AntiCoagulants (NOAC) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Oral AntiCoagulants (NOAC) revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Novel Oral AntiCoagulants (NOAC) revenues share in global market, 2020 (%)
Key companies Novel Oral AntiCoagulants (NOAC) sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Novel Oral AntiCoagulants (NOAC) sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Novel Oral AntiCoagulants (NOAC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Oral AntiCoagulants (NOAC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Oral AntiCoagulants (NOAC) Overall Market Size
2.1 Global Novel Oral AntiCoagulants (NOAC) Market Size: 2021 VS 2027
2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Novel Oral AntiCoagulants (NOAC) Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Novel Oral AntiCoagulants (NOAC) Players in Global Market
3.2 Top Global Novel Oral AntiCoagulants (NOAC) Companies Ranked by Revenue
3.3 Global Novel Oral AntiCoagulants (NOAC) Revenue by Companies
3.4 Global Novel Oral AntiCoagulants (NOAC) Sales by Companies
3.5 Global Novel Oral AntiCoagulants (NOAC) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Novel Oral AntiCoagulants (NOAC) Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Novel Oral AntiCoagulants (NOAC) Players in Global Market
3.8.1 List of Global Tier 1 Novel Oral AntiCoagulants (NOAC) Companies
3.8.2 List of Global Tier 2 and Tier 3 Novel Oral AntiCoagulants (NOAC) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Novel Oral AntiCoagulants (NOAC) Market Size Markets, 2021 & 2027
4.1.2 Direct Thrombin Inhibitors
4.1.3 Direct Factor Xa Inhibitors
4.2 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue & Forecasts
4.2.1 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2021
4.2.2 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2022-2027
4.2.3 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2016-2027
4.3 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales & Forecasts
4.3.1 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales, 2016-2021
4.3.2 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales, 2022-2027
4.3.3 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2016-2027
4.4 By Type - Global Novel Oral AntiCoagulants (NOAC) Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Novel Oral AntiCoagulants (NOAC) Market Size, 2021 & 2027
5.1.2 Deep Vein Thrombosis (DVT)
5.1.3 Pulmonary Embolism
5.1.4 Acute Coronary Syndrome
5.1.5 Hemodialysis
5.1.6 Others
5.2 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue & Forecasts
5.2.1 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2021
5.2.2 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2022-2027
5.2.3 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2016-2027
5.3 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales & Forecasts
5.3.1 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales, 2016-2021
5.3.2 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales, 2022-2027
5.3.3 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2016-2027
5.4 By Application - Global Novel Oral AntiCoagulants (NOAC) Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Novel Oral AntiCoagulants (NOAC) Market Size, 2021 & 2027
6.2 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue & Forecasts
6.2.1 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2021
6.2.2 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2022-2027
6.2.3 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2016-2027
6.3 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales & Forecasts
6.3.1 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales, 2016-2021
6.3.2 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales, 2022-2027
6.3.3 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2027
6.4.2 By Country - North America Novel Oral AntiCoagulants (NOAC) Sales, 2016-2027
6.4.3 US Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.4.4 Canada Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.4.5 Mexico Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2027
6.5.2 By Country - Europe Novel Oral AntiCoagulants (NOAC) Sales, 2016-2027
6.5.3 Germany Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5.4 France Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5.5 U.K. Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5.6 Italy Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5.7 Russia Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5.8 Nordic Countries Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.5.9 Benelux Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2027
6.6.2 By Region - Asia Novel Oral AntiCoagulants (NOAC) Sales, 2016-2027
6.6.3 China Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.6.4 Japan Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.6.5 South Korea Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.6.6 Southeast Asia Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.6.7 India Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2027
6.7.2 By Country - South America Novel Oral AntiCoagulants (NOAC) Sales, 2016-2027
6.7.3 Brazil Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.7.4 Argentina Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales, 2016-2027
6.8.3 Turkey Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.8.4 Israel Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.8.5 Saudi Arabia Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
6.8.6 UAE Novel Oral AntiCoagulants (NOAC) Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.1.4 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.2.4 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.3.4 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.4.4 Sanofi Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Corporate Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.5.4 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.5.5 Daiichi Sankyo Key News
7.6 Armatheon
7.6.1 Armatheon Corporate Summary
7.6.2 Armatheon Business Overview
7.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.6.4 Armatheon Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.6.5 Armatheon Key News
7.7 Aspen
7.7.1 Aspen Corporate Summary
7.7.2 Aspen Business Overview
7.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.4.4 Aspen Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.7.5 Aspen Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.8.4 AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.8.5 AstraZeneca Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.9.4 Bayer Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.9.5 Bayer Key News
7.10 Cellceutix
7.10.1 Cellceutix Corporate Summary
7.10.2 Cellceutix Business Overview
7.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.10.4 Cellceutix Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.10.5 Cellceutix Key News
7.11 Cosmo Pharmaceuticals
7.11.1 Cosmo Pharmaceuticals Corporate Summary
7.11.2 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Business Overview
7.11.3 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.11.4 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.11.5 Cosmo Pharmaceuticals Key News
7.12 CSL Behring
7.12.1 CSL Behring Corporate Summary
7.12.2 CSL Behring Novel Oral AntiCoagulants (NOAC) Business Overview
7.12.3 CSL Behring Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.12.4 CSL Behring Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.12.5 CSL Behring Key News
7.13 Eisai
7.13.1 Eisai Corporate Summary
7.13.2 Eisai Novel Oral AntiCoagulants (NOAC) Business Overview
7.13.3 Eisai Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.13.4 Eisai Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.13.5 Eisai Key News
7.14 GSK
7.14.1 GSK Corporate Summary
7.14.2 GSK Business Overview
7.14.3 GSK Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.14.4 GSK Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.14.5 GSK Key News
7.15 Marathon Pharmaceuticals
7.15.1 Marathon Pharmaceuticals Corporate Summary
7.15.2 Marathon Pharmaceuticals Business Overview
7.15.3 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.15.4 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.15.5 Marathon Pharmaceuticals Key News
7.16 Ockham Biotech
7.16.1 Ockham Biotech Corporate Summary
7.16.2 Ockham Biotech Business Overview
7.16.3 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.16.4 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.16.5 Ockham Biotech Key News
7.17 Perosphere
7.17.1 Perosphere Corporate Summary
7.17.2 Perosphere Business Overview
7.17.3 Perosphere Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.17.4 Perosphere Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2016-2021)
7.17.5 Perosphere Key News
8 Global Novel Oral AntiCoagulants (NOAC) Production Capacity, Analysis
8.1 Global Novel Oral AntiCoagulants (NOAC) Production Capacity, 2016-2027
8.2 Novel Oral AntiCoagulants (NOAC) Production Capacity of Key Manufacturers in Global Market
8.3 Global Novel Oral AntiCoagulants (NOAC) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Novel Oral AntiCoagulants (NOAC) Supply Chain Analysis
10.1 Novel Oral AntiCoagulants (NOAC) Industry Value Chain
10.2 Novel Oral AntiCoagulants (NOAC) Upstream Market
10.3 Novel Oral AntiCoagulants (NOAC) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Novel Oral AntiCoagulants (NOAC) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Novel Oral AntiCoagulants (NOAC) in Global Market
Table 2. Top Novel Oral AntiCoagulants (NOAC) Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Novel Oral AntiCoagulants (NOAC) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Novel Oral AntiCoagulants (NOAC) Revenue Share by Companies, 2016-2021
Table 5. Global Novel Oral AntiCoagulants (NOAC) Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Novel Oral AntiCoagulants (NOAC) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Novel Oral AntiCoagulants (NOAC) Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
Table 9. List of Global Tier 1 Novel Oral AntiCoagulants (NOAC) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Oral AntiCoagulants (NOAC) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE